华章科技(01673.HK)博荣贷款总协议已告终止
华章科技(01673.HK)就控股股东博荣控股牵涉在一宗争议中作进一步公布,贷款总协议、博荣与独立贷款方的抵押总协议及抵押品管理协议均已告终止。
涉嫌未获授权出售已抵押的800万股争议股份中,633.8万股及106.6万股已分别於6月6日及6月11日退回博荣的证券户口,而59.6万股则经订约各方同意由独立贷款方保留以抵销经纪托管费与独立贷款方行政费的合计价值。
此外,独立贷款人及经纪人均不享有退回至博荣证券户口的740.4万股争议股份及保留至证券户口的约1.23亿股已抵押抵押品当中拥有任何担保权益;及博荣持有合共约4.11亿股公司股份,相当於目前公司已发行股本约56.92%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.